Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal.

Kotlyar M, Brauer LH, al'absi M, Adson DE, Robiner W, Thuras P, Harris J, Finocchi ME, Bronars CA, Candell S, Hatsukami DK.

Pharmacol Biochem Behav. 2006 Mar;83(3):370-9. Epub 2006 Mar 6.

PMID:
16581115
2.

Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.

Kotlyar M, Drone D, Thuras P, Hatsukami DK, Brauer L, Adson DE, al'Absi M.

Nicotine Tob Res. 2011 Jun;13(6):492-7. doi: 10.1093/ntr/ntr011. Epub 2011 Mar 4.

3.

The effect of bupropion on nicotine craving and withdrawal.

Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J.

Psychopharmacology (Berl). 2000 Jan;148(1):33-40.

PMID:
10663415
4.

A comparison of sustained-release bupropion and placebo for smoking cessation.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

N Engl J Med. 1997 Oct 23;337(17):1195-202.

5.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.

N Engl J Med. 1999 Mar 4;340(9):685-91.

6.

Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.

Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A.

Psychopharmacology (Berl). 2005 Nov;183(1):1-12. Epub 2005 Oct 22.

PMID:
16160876
7.

Effect of paroxetine on physiological response to stress and smoking.

Kotlyar M, al'Absi M, Thuras P, Vuchetich JP, Adson DE, Nowack AL, Hatsukami DK.

Psychosom Med. 2013 Apr;75(3):236-43. doi: 10.1097/PSY.0b013e3182898f6d. Epub 2013 Mar 15.

8.

Bupropion for the treatment of nicotine withdrawal and craving.

Mooney ME, Sofuoglu M.

Expert Rev Neurother. 2006 Jul;6(7):965-81. Review.

PMID:
16831112
9.

Acute doses of d-amphetamine and bupropion increase cigarette smoking.

Cousins MS, Stamat HM, de Wit H.

Psychopharmacology (Berl). 2001 Sep;157(3):243-53.

PMID:
11605079
10.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
11.

Possible reinforcement enhancing effects of bupropion during initial smoking abstinence.

Perkins KA, Karelitz JL, Jao NC, Stratton E.

Nicotine Tob Res. 2013 Jun;15(6):1141-5. doi: 10.1093/ntr/nts224. Epub 2012 Oct 24.

12.

Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.

Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A.

Psychopharmacology (Berl). 2002 Nov;164(2):177-87. Epub 2002 Aug 27.

PMID:
12404080
13.

[Bupropion. An antidepressant used to help smoking cessation].

Taeron C.

Rev Infirm. 2002 May;(81):47-9. French. No abstract available.

PMID:
12078615
14.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
15.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
16.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
17.

Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers.

al'Absi M, Wittmers LE, Erickson J, Hatsukami D, Crouse B.

Pharmacol Biochem Behav. 2003 Jan;74(2):401-10.

PMID:
12479961
18.

Nicotine withdrawal and stress-induced changes in pain sensitivity: a cross-sectional investigation between abstinent smokers and nonsmokers.

Nakajima M, Al'Absi M.

Psychophysiology. 2014 Oct;51(10):1015-22. doi: 10.1111/psyp.12241. Epub 2014 Jun 17.

19.

Bupropion SR worsens mood during marijuana withdrawal in humans.

Haney M, Ward AS, Comer SD, Hart CL, Foltin RW, Fischman MW.

Psychopharmacology (Berl). 2001 May;155(2):171-9.

PMID:
11401006
20.

Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers.

Martins LC, Ferreira-Melo SE, Sabha M, Coelho OR, Yugar-Toledo JC, Quinaglia T, Moreira MM, Coca A, Moreno JĂșnior H.

Blood Press. 2009;18(5):255-60. doi: 10.3109/08037050903289606.

PMID:
19919396

Supplemental Content

Support Center